Global Health Share Price
Sector: Healthcare Facilities
1268.15 -29.85 (-2.30%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1262.75
Today’s High
1298.00
52 Week Low
936.05
52 Week High
1510.10
1269.10 -26.20 (-2.02%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1263.10
Today’s High
1298.70
52 Week Low
935.50
52 Week High
1511.00
Key Metrics
- Market Cap (In Cr) 34060.91
- Beta -
- Div. Yield (%) 0
- P/B 11.73
- TTM P/E 57.12
- Sector P/E 22.83
- Open Price 1275.65
- Prev Close 1298
Global Health Analysis
Price Analysis
-
1 Week2.5%
-
3 Months23.57%
-
6 Month17.73%
-
YTD17.67%
-
1 Year-8.47%
Risk Meter
- 35% Low risk
- 35% Moderate risk
- 35% Balanced Risk
- 35% High risk
- 35% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 5
- 5
- 5
- 3
- Buy
- 2
- 2
- 2
- 2
- Hold
- 2
- 2
- 2
- 3
- Sell
- 2
- 2
- 2
- 2
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 11
- 11
- 11
- 10
Global Health News
US Tariff Woes: Emkay cuts Tata Motors target to ₹800 but retains 'buy' call
2 min read . 16 Apr 2025Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy
1 min read . 16 Apr 2025Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares for today
2 min read . 15 Apr 2025Global Health Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 3275.11
- Selling/ General/ Admin Expenses Total
- 1698.6
- Depreciation/ Amortization
- 172.73
- Other Operating Expenses Total
- 4.9
- Total Operating Expense
- 2635.63
- Operating Income
- 639.48
- Net Income Before Taxes
- 627.1
- Net Income
- 478.19
- Diluted Normalized EPS
- 17.78
- Period
- 2024
- Total Assets
- 4304.08
- Total Liabilities
- 1398.45
- Total Equity
- 2905.63
- Tangible Book Valueper Share Common Eq
- 108.01
- Period
- 2024
- Cashfrom Operating Activities
- 612.08
- Cashfrom Investing Activities
- -440.79
- Cashfrom Financing Activities
- -513.92
- Net Changein Cash
- -342.64
- Period
- 2023
- Total Revenue
- 2694.25
- Selling/ General/ Admin Expenses Total
- 1436.84
- Depreciation/ Amortization
- 149.91
- Other Operating Expenses Total
- 3.49
- Total Operating Expense
- 2215.57
- Operating Income
- 478.68
- Net Income Before Taxes
- 449.29
- Net Income
- 326.08
- Diluted Normalized EPS
- 12.59
- Period
- 2023
- Total Assets
- 4115.96
- Total Liabilities
- 1687.76
- Total Equity
- 2428.21
- Tangible Book Valueper Share Common Eq
- 90.35
- Period
- 2023
- Cashfrom Operating Activities
- 644.52
- Cashfrom Investing Activities
- -342.34
- Cashfrom Financing Activities
- 345.64
- Net Changein Cash
- 647.81
- Period
- 2022
- Total Revenue
- 2166.59
- Selling/ General/ Admin Expenses Total
- 1165.26
- Depreciation/ Amortization
- 129.71
- Other Operating Expenses Total
- 6
- Total Operating Expense
- 1843.95
- Operating Income
- 322.64
- Net Income Before Taxes
- 280.56
- Net Income
- 196.2
- Diluted Normalized EPS
- 7.25
- Period
- 2022
- Total Assets
- 3145.52
- Total Liabilities
- 1529.51
- Total Equity
- 1616.01
- Tangible Book Valueper Share Common Eq
- 60.02
- Period
- 2022
- Cashfrom Operating Activities
- 311.26
- Cashfrom Investing Activities
- -420.89
- Cashfrom Financing Activities
- 159.59
- Net Changein Cash
- 49.97
- Period
- 2021
- Total Revenue
- 1446.74
- Selling/ General/ Admin Expenses Total
- 897.85
- Depreciation/ Amortization
- 123.21
- Other Operating Expenses Total
- 4.76
- Total Operating Expense
- 1375.66
- Operating Income
- 71.08
- Net Income Before Taxes
- 32.46
- Net Income
- 28.81
- Diluted Normalized EPS
- 1.06
- Period
- 2021
- Total Assets
- 2694.11
- Total Liabilities
- 1311.76
- Total Equity
- 1382.34
- Tangible Book Valueper Share Common Eq
- 50.06
- Period
- 2021
- Cashfrom Operating Activities
- 241.77
- Cashfrom Investing Activities
- -239.15
- Cashfrom Financing Activities
- -80.72
- Net Changein Cash
- -78.1
- Period
- 2020
- Total Revenue
- 1500.42
- Selling/ General/ Admin Expenses Total
- 983.52
- Depreciation/ Amortization
- 115.04
- Other Operating Expenses Total
- 2.6
- Total Operating Expense
- 1425.97
- Operating Income
- 74.45
- Net Income Before Taxes
- 63.87
- Net Income
- 36.33
- Diluted Normalized EPS
- 1.36
- Period
- 2020
- Total Assets
- 2666.29
- Total Liabilities
- 1316.75
- Total Equity
- 1349.54
- Tangible Book Valueper Share Common Eq
- 48.79
- Period
- 2020
- Cashfrom Operating Activities
- 175.07
- Cashfrom Investing Activities
- -87.07
- Cashfrom Financing Activities
- -0.88
- Net Changein Cash
- 87.12
- Period
- 2024-12-31
- Total Revenue
- 943.44
- Selling/ General/ Admin Expenses Total
- 329.96
- Depreciation/ Amortization
- 48.45
- Other Operating Expenses Total
- 143.1
- Total Operating Expense
- 754.12
- Operating Income
- 189.32
- Net Income Before Taxes
- 189.07
- Net Income
- 142.91
- Diluted Normalized EPS
- 5.42
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 956.56
- Selling/ General/ Admin Expenses Total
- 336.62
- Depreciation/ Amortization
- 49.43
- Other Operating Expenses Total
- 157.58
- Total Operating Expense
- 777.7
- Operating Income
- 178.86
- Net Income Before Taxes
- 181.1
- Net Income
- 130.84
- Diluted Normalized EPS
- 5.03
- Period
- 2024-09-30
- Total Assets
- 4510.08
- Total Liabilities
- 1368.6
- Total Equity
- 3141.49
- Tangible Book Valueper Share Common Eq
- 116.64
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 299.27
- Cashfrom Investing Activities
- -308.91
- Cashfrom Financing Activities
- -115.2
- Net Changein Cash
- -124.84
- Period
- 2024-06-30
- Total Revenue
- 861.08
- Selling/ General/ Admin Expenses Total
- 319.66
- Depreciation/ Amortization
- 46.62
- Other Operating Expenses Total
- 141.32
- Total Operating Expense
- 721.37
- Operating Income
- 139.7
- Net Income Before Taxes
- 143.65
- Net Income
- 106.29
- Diluted Normalized EPS
- 4.1
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 825.53
- Selling/ General/ Admin Expenses Total
- 308.12
- Depreciation/ Amortization
- 45.45
- Other Operating Expenses Total
- 127.42
- Total Operating Expense
- 674.74
- Operating Income
- 150.79
- Net Income Before Taxes
- 143.09
- Net Income
- 127.38
- Diluted Normalized EPS
- 4.73
- Period
- 2024-03-31
- Total Assets
- 4304.08
- Total Liabilities
- 1398.45
- Total Equity
- 2905.63
- Tangible Book Valueper Share Common Eq
- 108.01
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 612.08
- Cashfrom Investing Activities
- -440.79
- Cashfrom Financing Activities
- -513.92
- Net Changein Cash
- -342.64
- Period
- 2023-12-31
- Total Revenue
- 832.6
- Selling/ General/ Admin Expenses Total
- 302.08
- Depreciation/ Amortization
- 43.98
- Other Operating Expenses Total
- 127.76
- Total Operating Expense
- 664.49
- Operating Income
- 168.11
- Net Income Before Taxes
- 172.36
- Net Income
- 123.64
- Diluted Normalized EPS
- 4.6
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 843.94
- Selling/ General/ Admin Expenses Total
- 296.61
- Depreciation/ Amortization
- 42.91
- Other Operating Expenses Total
- 140.9
- Total Operating Expense
- 674
- Operating Income
- 169.94
- Net Income Before Taxes
- 170.6
- Net Income
- 125.16
- Diluted Normalized EPS
- 4.66
- Period
- 2023-09-30
- Total Assets
- 4079.47
- Total Liabilities
- 1425.34
- Total Equity
- 2654.13
- Tangible Book Valueper Share Common Eq
- 98.71
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 282.6
- Cashfrom Investing Activities
- -225.51
- Cashfrom Financing Activities
- -470.37
- Net Changein Cash
- -413.28
- Period
- 2023-06-30
- Total Revenue
- 773.04
- Selling/ General/ Admin Expenses Total
- 284.39
- Depreciation/ Amortization
- 40.38
- Other Operating Expenses Total
- 129.4
- Total Operating Expense
- 635.54
- Operating Income
- 137.5
- Net Income Before Taxes
- 141.04
- Net Income
- 102.01
- Diluted Normalized EPS
- 3.8
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 703.42
- Selling/ General/ Admin Expenses Total
- 252.73
- Depreciation/ Amortization
- 37.95
- Other Operating Expenses Total
- 122.81
- Total Operating Expense
- 578.27
- Operating Income
- 125.15
- Net Income Before Taxes
- 133.08
- Net Income
- 101.07
- Diluted Normalized EPS
- 3.76
- Period
- 2023-03-31
- Total Assets
- 4115.96
- Total Liabilities
- 1687.76
- Total Equity
- 2428.21
- Tangible Book Valueper Share Common Eq
- 90.35
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 644.52
- Cashfrom Investing Activities
- -342.34
- Cashfrom Financing Activities
- 345.64
- Net Changein Cash
- 647.81
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Global Health Technical
Moving Average
SMA
- 5 Day1267.8
- 10 Day1249.23
- 20 Day1240.08
- 50 Day1191.82
- 100 Day1138.56
- 300 Day1133.03
Global Health Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Fortis Healthcare
- 661.7
- 12.25
- 1.89
- 744
- 406.35
- 49955.58
- Narayana Hrudayalaya
- 1854.95
- 61.85
- 3.45
- 1861
- 1087.8
- 37907.91
- Global Health
- 1268.15
- -29.85
- -2.3
- 1510.1
- 936.05
- 34060.91
- Krishna Instit Of Medical Scienc
- 652.4
- 7.6
- 1.18
- 674
- 350.02
- 26105.06
- Aster Dm Healthcare
- 499.6
- -0.75
- -0.15
- 534
- 312.25
- 24955.67
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Fortis Healthcare
- 85.86
- 6.55
- 5.07
- 7.63
- Narayana Hrudayalaya
- 47.45
- 13.14
- 23.44
- 9.72
- Global Health
- 71.38
- 11.73
- -
- -
- Krishna Instit Of Medical Scienc
- 84.52
- 14.32
- 22.79
- 15.53
- Aster Dm Healthcare
- 203.23
- 5.45
- 6.24
- 4.26
Global Health Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 04-Feb-25
- Quarterly Results
- 14-Nov-24
- Quarterly Results
- 08-Aug-24
- Quarterly Results
- 17-May-24
- Audited Results
- 08-Feb-24
- Quarterly Results
- 09-Nov-23
- Quarterly Results
- 10-Aug-23
- Quarterly Results
- 27-May-23
- Audited Results
- 13-Feb-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 17-Mar-25
- 11-Feb-25
- POM
- 29-Dec-24
- 26-Nov-24
- POM
- 19-Sept-24
- 08-Aug-24
- AGM
- 03-Aug-24
- 02-Jul-24
- COM
- 20-Sept-23
- 10-Aug-23
- AGM



